An elderly American man has become completely blind after he was prescribed to take Ozempic to manage his type 2 diabetes.

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

Todd Engel, a Maryland man, is suing Ozempic maker Novo Nordisk after allegedly going blind due to the drug, raising concerns ...

The Danish Chamber of Commerce Malaysia (DanCham) took part in a high-level networking reception on Tuesday 22 April 2025, ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Other drugs in development for CHB include Dicerna (now part of Novo Nordisk) and Roche’s siRNA candidate xalnesiran, which reported phase 2 data at the AASLD conference last year, and Arrowhead ...